2seventy bio, the cell therapy spinout of Bluebird bio, is selling itself to Bristol Myers Squibb after losing most of its market value in its short run as an independent biotechnology company. Per ...

Bluebird Bio and its three approved lentiviral gene therapies are being acquired by investment firms Carlyle and SK Capital for less than US$30 million. The biotech had a market capitalization of ...

Blue­bird bio went from a high-fly­ing $10 bil­lion com­pa­ny in 2018 dur­ing the hey­day of gene ther­a­py to be­ing sold for a measly $29 mil­lion … ...

Parents need to know that 2001: A Space Odyssey is the 1969 classic Stanley Kubrick adaptation of the Arthur C. Clarke novel. While many think it's one of the greatest films ever made and was the ...

Bluebird Kids Health, a value-based pediatric primary care provider, has closed its series A round with $31.5 million. The round was co-led by F Prime and .406 Ventures with participation from ...

BOSTON, March 4, 2025 /PRNewswire/ -- Bluebird Kids Health, a new healthcare services company designed to deliver value-based pediatric primary care, today announced the closing of a $31.5 million ...